B. Oosterhuis

Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs

Graham Lappin, W. Kuhnz, R. Jochemsen et al. · Clinical Pharmacology & Therapeutics · 2006 · 242 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Metabolism and Excretion of the Once-Daily Human Glucagon-Like Peptide-1 Analog Liraglutide in Healthy Male Subjects and Its In Vitro Degradation by Dipeptidyl Peptidase IV and Neutral Endopeptidase

Monika Malm-Erjefält, Inga Bjørnsdottir, Jan Vanggaard et al. · Drug Metabolism and Disposition · 2010 · 197 citations

Pharmacy, Endocrinology, Pharmacology +16

CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences

Wim J. Tamminga, J. Wemer, B. Oosterhuis et al. · European Journal of Clinical Pharmacology · 1999 · 144 citations

Medicine, Endocrinology, Gynecology +16

Pharmacokinetics of fexofenadine: Evaluation of a microdose and assessment of absolute oral bioavailability

Graham Lappin, Yoko Shishikura, Roeline Jochemsen et al. · European Journal of Pharmaceutical Sciences · 2010 · 113 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteers

Wim J. Tamminga, J. Wemer, B. Oosterhuis et al. · European Journal of Clinical Pharmacology · 2001 · 99 citations

Life Sciences, Genetics, Pharmacology +10